PD-1 expression is enhanced on CD8+ T effector cells in HCC, and PD-1 interacts with tumors producing PD-L1/2, which suppresses T-cell signaling, proliferation, and cytokine production [137,138]. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.